Â
Â
Â
Â
Cardiex Limited (ASX: CDX) has marked a pivotal milestone with the U.S. launch of the CONNEQT Pulse, the world’s most advanced personal arterial health monitor, alongside its companion digital platform, the CONNEQT App. This strategic dual launch aims to transform cardiovascular health management by combining cutting-edge technology with actionable health insights.
Â
Â
Â
Deliveries of the first 3,000 CONNEQT Pulse units have begun, with an additional 5,000 units from Cardiex’s (ASX: CDX) manufacturing partner, Andon, en route to the company’s U.S. fulfillment facility. The Pulse, built on Cardiex’s (ASX: CDX) proprietary SphygmoCor® vascular biomarker technology, offers users unparalleled insights into arterial health, making it a game-changer in personal health monitoring.
Â
CEO Craig Cooper emphasized the significance of the launch, "The Pulse and CONNEQT App together provide a unique and impactful foundation for fostering healthier outcomes. The early feedback has been overwhelmingly positive, signaling a transformative change in arterial health monitoring."
Â
Â
Â
The CONNEQT App, now available for download on both iOS and Android, enhances the Pulse experience by providing users with a suite of features designed to empower them on their cardiovascular health journey.
Â
Key Features:
Â
Â
Â
Â
The initial response to the CONNEQT Pulse and App has been highly encouraging. Early sales trends indicate strong week-over-week growth, driven by a combination of pre-order fulfillment and targeted online marketing campaigns.
Â
Cardiex’s (ASX: CDX) focus on customer education and engagement has further strengthened its positioning in the U.S. market. With its comprehensive ecosystem, the company is poised to redefine how individuals monitor and manage their cardiovascular health.
Â
Â
Â
As Cardiex (ASX: CDX) continues to execute its launch strategy, the integration of the CONNEQT Pulse and App positions the company as a leader in vascular health technology. The innovative features of the Pulse, combined with the App’s ability to provide actionable insights and guided health programs, highlight Cardiex’s (ASX: CDX) commitment to improving health outcomes and increasing longevity.
Â
The company’s strategic efforts in expanding its reach and leveraging its advanced technology set the stage for a promising year ahead.
Disclaimer - Skrill Network is designed solely for educational and informational use. The content on this website should not be considered as investment advice or a directive. Before making any investment choices, it is crucial to carry out your own research, taking into account your individual investment objectives and personal situation. If you're considering investment decisions influenced by the information on this website, you should either seek independent financial counsel from a qualified expert or independently verify and research the information.
Tags:
RECENT POSTS
TAGS
Subscribe to the Skrill Network Newsletter today and stay informed
Recommended Articles